homocysteine and dihydroxyphenylalanine

homocysteine has been researched along with dihydroxyphenylalanine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beaton, JM1
York, DH1
Blandini, F; Fancellu, R; Mangiagalli, A; Martignoni, E; Nappi, G; Pacchetti, C; Samuele, A1
Fowler, B; Kuhn, W; Müller, T; Woitalla, D1
Kuhn, W; Müller, T1
Muhlack, S; Müller, T1
Bhidayasiri, R; Boonla, C; Chotipanich, C; Dissayabutra, T; Joutsa, J; Kaewwilai, L; Muensri, S; Rinne, J; Tosukhowong, P1
Herrman, L; Kinkel, M; Muhlack, S; Müller, T1

Reviews

1 review(s) available for homocysteine and dihydroxyphenylalanine

ArticleYear
Methylation & schizophrenia.
    The Alabama journal of medical sciences, 1975, Volume: 12, Issue:2

    Topics: Amines; Amino Acids; Animals; Behavior, Animal; Catecholamines; Cats; Cystathionine; Cysteine; Dihydroxyphenylalanine; Drug Tolerance; Hallucinogens; Homocysteine; Humans; Indoles; Methionine; Methylation; Mice; Schizophrenia; Serine; Taurine

1975

Trials

2 trial(s) available for homocysteine and dihydroxyphenylalanine

ArticleYear
Homocysteine levels after acute levodopa intake in patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jul-15, Volume: 24, Issue:9

    Topics: Aged; Analysis of Variance; Antiparkinson Agents; Dihydroxyphenylalanine; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Statistics as Topic; Time Factors; Tyrosine

2009
Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study.
    Journal of the neurological sciences, 2016, Aug-15, Volume: 367

    Topics: Amino Acids; Antiparkinson Agents; Brain; Dietary Supplements; Dihydroxyphenylalanine; Double-Blind Method; Female; Follow-Up Studies; Glutathione; Homocysteine; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Severity of Illness Index; Soybean Proteins; Treatment Outcome; Whey Proteins

2016

Other Studies

5 other study(ies) available for homocysteine and dihydroxyphenylalanine

ArticleYear
Dopamine receptor blockade--a central action of chlorpromazine on striatal neurones.
    Brain research, 1972, Feb-11, Volume: 37, Issue:1

    Topics: Action Potentials; Adrenergic alpha-Antagonists; Animals; Basal Ganglia; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Globus Pallidus; Haplorhini; Homocysteine; Iontophoresis; Sensory Receptor Cells

1972
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.
    Clinical chemistry, 2001, Volume: 47, Issue:6

    Topics: Antiparkinson Agents; Dihydroxyphenylalanine; Dopamine; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tyrosine

2001
3-OMD and homocysteine plasma levels in parkinsonian patients.
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:2

    Topics: Dihydroxyphenylalanine; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tyrosine

2002
Peripheral COMT inhibition prevents levodopa associated homocysteine increase.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Delayed-Action Preparations; Dihydroxyphenylalanine; Enzyme Inhibitors; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Time Factors; Tyrosine

2009
Levodopa, placebo and rotigotine change biomarker levels for oxidative stress.
    Neurological research, 2017, Volume: 39, Issue:5

    Topics: Aged; Analysis of Variance; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dipeptides; Dopamine Agents; Electrochemical Techniques; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes; Time Factors; Tyrosine

2017